These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 24599583)

  • 1. Inhibitor of differentiation 1 is a candidate prognostic marker in multicentric Castleman's disease.
    Liu C; Liu YR; Chen J; Zhuo SY; Dalin M; Liu SH; Wei FC
    Ann Hematol; 2014 Jul; 93(7):1177-83. PubMed ID: 24599583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic multicentric Castleman's disease. A clinicopathologic and immunohistochemical study of five cases.
    Kojima M; Nakamura S; Nishikawa M; Itoh H; Miyawaki S; Masawa N
    Pathol Res Pract; 2005; 201(4):325-32. PubMed ID: 15991840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in soluble CD138 in bronchoalveolar lavage fluid of multicentric Castleman's disease.
    Hasegawa M; Betsuyaku T; Yoshida N; Nasuhara Y; Kinoshita I; Ohta S; Itoh T; Park PW; Nishimura M
    Respirology; 2007 Jan; 12(1):140-3. PubMed ID: 17207040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases.
    Sato Y; Kojima M; Takata K; Morito T; Mizobuchi K; Tanaka T; Inoue D; Shiomi H; Iwao H; Yoshino T
    J Clin Pathol; 2010 Dec; 63(12):1084-9. PubMed ID: 20974624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct expression of Kaposi's sarcoma-associated herpesvirus-encoded proteins in Kaposi's sarcoma and multicentric Castleman's disease.
    Abe Y; Matsubara D; Gatanaga H; Oka S; Kimura S; Sasao Y; Saitoh K; Fujii T; Sato Y; Sata T; Katano H
    Pathol Int; 2006 Oct; 56(10):617-24. PubMed ID: 16984619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Castleman's disease of the leptomeninges--immunohistochemical findings in 2 cases.
    Ropponen KM; Kankkunen JP; Ronkainen A; Vihavainen M; Alafuzoff I
    Clin Neuropathol; 2002; 21(6):278-83. PubMed ID: 12489677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castleman's disease. Update on pathogenesis.
    Al-Maghrabi JA
    Saudi Med J; 2011 May; 32(5):451-8. PubMed ID: 21556463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare presentation of unicentric Castleman's disease in the parotid gland.
    Reece B; Ord R; Papadimitriou J
    J Oral Maxillofac Surg; 2012 Sep; 70(9):2114-7. PubMed ID: 22305675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
    Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
    Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicentric Castleman's disease (MCD): recent knowledge of its pathogenesis].
    Higashibara M; Horie R; Yoneyama A; Mori S
    Rinsho Ketsueki; 1992 Nov; 33(11):1649-60. PubMed ID: 1469779
    [No Abstract]   [Full Text] [Related]  

  • 12. Multicentric Castleman's disease in a child with prominent thymic involvement: a case report and brief review of the literature.
    O'Reilly PE; Joshi VV; Holbrook CT; Weisenburger DD
    Mod Pathol; 1993 Nov; 6(6):776-80. PubMed ID: 8302822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic relevance of Id1 in stage III esophageal squamous cell carcinoma.
    Liu J; Hu Y; Hu W; Xie X; Ela Bella A; Fu J
    Cancer Biomark; 2010-2011; 8(2):67-72. PubMed ID: 21896993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
    Ushio K; Hashimoto T; Kitamura N; Tanaka T
    Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Castleman's disease. A case report.
    Arslan D; Oztürk F; Patiroğlu T; Küçükaydin M; Gündüz Z
    Turk J Pediatr; 1996; 38(3):361-6. PubMed ID: 8827907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrence of localized Castleman's disease and peripheral small B-Lymphocytic lymphoma within the same lymph node.
    Orcioni GF; Mambelli V; Ascani S; Sabattini E; Piccioli M; Pieri F; Falini B; Pileri SA
    Gen Diagn Pathol; 1998 Apr; 143(5-6):327-30. PubMed ID: 9653916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide.
    Lee FC; Merchant SH
    Am J Hematol; 2003 May; 73(1):48-53. PubMed ID: 12701121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colocalization of the viral interleukin-6 with latent nuclear antigen-1 of human herpesvirus-8 in endothelial spindle cells of Kaposi's sarcoma and lymphoid cells of multicentric Castleman's disease.
    Brousset P; Cesarman E; Meggetto F; Lamant L; Delsol G
    Hum Pathol; 2001 Jan; 32(1):95-100. PubMed ID: 11172301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Castleman's disease of the bilateral parotid gland: a case report.
    Akdogan O; Sarikaya Y; Dere H; Bahar S; Firat Y
    B-ENT; 2006; 2(4):185-7. PubMed ID: 17256406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients.
    Oksenhendler E; Duarte M; Soulier J; Cacoub P; Welker Y; Cadranel J; Cazals-Hatem D; Autran B; Clauvel JP; Raphael M
    AIDS; 1996 Jan; 10(1):61-7. PubMed ID: 8924253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.